Jun 15, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
Relapse-Free Survival Now Easier To Predict For Several Tumor Stages In Neuroendocrin
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2685220" data-attributes="member: 124445"><p>Researchers at Moffitt Cancer Center have carried out a study to validate the utility of new tumor classification systems for staging and predicting relapse-free survival for patients with neuroendocrine tumors (NETs) and who may be candidates for surgery. The results of their study were published in a recent issue of the Annals of Surgery. Neuroendocrine tumors, which form in the islet cells of the pancreas, are a relatively rare form of cancer, accounting for about 3 percent of all pancreatic malignancies. NETs that have not spread are treated surgically...<img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/ZWOCF7MWGn8" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/ZWOCF7MWGn8/243775.php" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2685220, member: 124445"] Researchers at Moffitt Cancer Center have carried out a study to validate the utility of new tumor classification systems for staging and predicting relapse-free survival for patients with neuroendocrine tumors (NETs) and who may be candidates for surgery. The results of their study were published in a recent issue of the Annals of Surgery. Neuroendocrine tumors, which form in the islet cells of the pancreas, are a relatively rare form of cancer, accounting for about 3 percent of all pancreatic malignancies. NETs that have not spread are treated surgically...[IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/ZWOCF7MWGn8[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/ZWOCF7MWGn8/243775.php]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top